Contineum Therapeutics, Inc. Class A (CTNM) has issued an announcement.
Continuum Therapeutics has updated its corporate presentation on its website and will not be filing a Form 8-K for each future update. The company emphasizes that this information should be viewed alongside its SEC filings and other public statements. Although Continuum is not obligated to revise these updates, it may choose to do so if deemed appropriate by management or as mandated by law.
For detailed information about CTNM stock, go to TipRanks’ Stock Analysis page.
